The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

All News

Brazilian Health Authorities Recognize Bifidobacterium Lactis HN019™ as Beneficial to Gastrointestinal Health
Biotics and Supplements

Brazilian Health Authorities Recognize Bifidobacterium Lactis HN019™ as Beneficial to Gastrointestinal Health

MAY 25, 2018
Oragenics, Inc. and Texas A&M University System Granted U.S. Patent for Lantibiotic MU1140
Infectious Disease & AMR

Oragenics, Inc. and Texas A&M University System Granted U.S. Patent for Lantibiotic MU1140

MAY 24, 2018
Management Changes at BioGaia
Finance

Management Changes at BioGaia

MAY 24, 2018
Monotherapy Trial Approved; the First Live Biotherapeutic Trial in Cancer
Oncology

Monotherapy Trial Approved; the First Live Biotherapeutic Trial in Cancer

MAY 21, 2018
Scioto Biosciences Closes $1.8M in Series A Financing
Finance

Scioto Biosciences Closes $1.8M in Series A Financing

MAY 21, 2018
New AZO Product Restores and Protects Vaginal Health
Pharma & Human Health

New AZO Product Restores and Protects Vaginal Health

MAY 17, 2018
Merck to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children
Biotics and Supplements

Merck to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children

MAY 17, 2018
Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update
Finance

Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update

MAY 16, 2018
Thryve Secures $1.4 Million Funding to Expand Personalized Probiotics and Individual Microbiome Testing
Biotics and Supplements

Thryve Secures $1.4 Million Funding to Expand Personalized Probiotics and Individual Microbiome Testing

MAY 16, 2018
Chr. Hansen reaches major milestone in innovation pipeline
Biotics and Supplements

Chr. Hansen reaches major milestone in innovation pipeline

MAY 16, 2018
Synlogic Announces Leadership Change
Biotics and Supplements

Synlogic Announces Leadership Change

MAY 11, 2018